0001171843-21-001708.txt : 20210311 0001171843-21-001708.hdr.sgml : 20210311 20210311170812 ACCESSION NUMBER: 0001171843-21-001708 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20210309 FILED AS OF DATE: 20210311 DATE AS OF CHANGE: 20210311 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Blanchard Cheryl R CENTRAL INDEX KEY: 0001326530 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-14027 FILM NUMBER: 21734145 MAIL ADDRESS: STREET 1: C/O ZIMMER, INC. STREET 2: P.O. BOX 708 CITY: WARSAW STATE: IN ZIP: 46580 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Anika Therapeutics, Inc. CENTRAL INDEX KEY: 0000898437 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 043145961 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 32 WIGGINS AVENUE CITY: BEDFORD STATE: MA ZIP: 01730 BUSINESS PHONE: (781) 457-9000 MAIL ADDRESS: STREET 1: 32 WIGGINS AVENUE CITY: BEDFORD STATE: MA ZIP: 01730 FORMER COMPANY: FORMER CONFORMED NAME: ANIKA THERAPEUTICS INC DATE OF NAME CHANGE: 19970114 FORMER COMPANY: FORMER CONFORMED NAME: ANIKA RESEARCH INC DATE OF NAME CHANGE: 19930309 4 1 ownership.xml X0306 4 2021-03-09 0 0000898437 Anika Therapeutics, Inc. ANIK 0001326530 Blanchard Cheryl R 32 WIGGINS AVENUE BEDFORD MA 01730 1 1 0 0 President, CEO, Director Restricted Stock Unit 0.00 2021-03-09 4 A 0 43259 0 A Common Stock 43259 43259 D Stock Option (Right to Buy) 37.40 2021-03-09 4 A 0 108398 0 A 2031-03-09 Common Stock 108398 108398 D Each RSU represents the contingent right to receive one share of the Company's common stock. The RSUs vest in three equal annual installments beginning March 9, 2022. Represents a 10% premium above the closing price of Anika's common stock on the date of grant. The premium priced stock options vest in three equal annual installments beginning on March 9, 2022. /s/ Cheryl R. Blanchard 2021-03-11